295 related articles for article (PubMed ID: 33109613)
1. A drug-resistant β-lactamase variant changes the conformation of its active-site proton shuttle to alter substrate specificity and inhibitor potency.
Soeung V; Lu S; Hu L; Judge A; Sankaran B; Prasad BVV; Palzkill T
J Biol Chem; 2020 Dec; 295(52):18239-18255. PubMed ID: 33109613
[TBL] [Abstract][Full Text] [Related]
2. The Drug-Resistant Variant P167S Expands the Substrate Profile of CTX-M β-Lactamases for Oxyimino-Cephalosporin Antibiotics by Enlarging the Active Site upon Acylation.
Patel MP; Hu L; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
Biochemistry; 2017 Jul; 56(27):3443-3453. PubMed ID: 28613873
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
[No Abstract] [Full Text] [Related]
4. KPC-2 β-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate.
Mehta SC; Furey IM; Pemberton OA; Boragine DM; Chen Y; Palzkill T
J Biol Chem; 2021; 296():100155. PubMed ID: 33273017
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis and structural analysis reveal the CTX-M β-lactamase active site is optimized for cephalosporin catalysis and drug resistance.
Lu S; Montoya M; Hu L; Neetu N; Sankaran B; Prasad BVV; Palzkill T
J Biol Chem; 2023 May; 299(5):104630. PubMed ID: 36963495
[TBL] [Abstract][Full Text] [Related]
6. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
Papp-Wallace KM; Winkler ML; Taracila MA; Bonomo RA
Antimicrob Agents Chemother; 2015 Jul; 59(7):3710-7. PubMed ID: 25666153
[TBL] [Abstract][Full Text] [Related]
7. Avibactam and inhibitor-resistant SHV β-lactamases.
Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis of beta-lactamase TEM-1. Investigating the potential role of specific residues on the activity of Pseudomonas-specific enzymes.
Lenfant F; Petit A; Labia R; Maveyraud L; Samama JP; Masson JM
Eur J Biochem; 1993 Nov; 217(3):939-46. PubMed ID: 8223651
[TBL] [Abstract][Full Text] [Related]
9. Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.
Li M; Conklin BC; Taracila MA; Hutton RA; Skalweit MJ
Antimicrob Agents Chemother; 2012 Nov; 56(11):5678-86. PubMed ID: 22908166
[TBL] [Abstract][Full Text] [Related]
10. A triple mutant in the Ω-loop of TEM-1 β-lactamase changes the substrate profile via a large conformational change and an altered general base for catalysis.
Stojanoski V; Chow DC; Hu L; Sankaran B; Gilbert HF; Prasad BV; Palzkill T
J Biol Chem; 2015 Apr; 290(16):10382-94. PubMed ID: 25713062
[TBL] [Abstract][Full Text] [Related]
11. Cyclic Boronates Inhibit All Classes of β-Lactamases.
Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
[TBL] [Abstract][Full Text] [Related]
12. Natural variants modify Klebsiella pneumoniae carbapenemase (KPC) acyl-enzyme conformational dynamics to extend antibiotic resistance.
Tooke CL; Hinchliffe P; Bonomo RA; Schofield CJ; Mulholland AJ; Spencer J
J Biol Chem; 2021; 296():100126. PubMed ID: 33257320
[TBL] [Abstract][Full Text] [Related]
13. Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
Papp-Wallace KM; Taracila M; Hornick JM; Hujer AM; Hujer KM; Distler AM; Endimiani A; Bonomo RA
Antimicrob Agents Chemother; 2010 Jul; 54(7):2867-77. PubMed ID: 20421396
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for the catalytic specificity of the CTX-M extended-spectrum β-lactamases.
Adamski CJ; Cardenas AM; Brown NG; Horton LB; Sankaran B; Prasad BV; Gilbert HF; Palzkill T
Biochemistry; 2015 Jan; 54(2):447-57. PubMed ID: 25489790
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of proton transfer in class A β-lactamase catalysis and inhibition by avibactam.
Pemberton OA; Noor RE; Kumar M V V; Sanishvili R; Kemp MT; Kearns FL; Woodcock HL; Gelis I; Chen Y
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5818-5825. PubMed ID: 32123084
[TBL] [Abstract][Full Text] [Related]
16. Structure, Function of Serine and Metallo-β-lactamases and their Inhibitors.
Salahuddin P; Kumar A; Khan AU
Curr Protein Pept Sci; 2018; 19(2):130-144. PubMed ID: 28745223
[TBL] [Abstract][Full Text] [Related]
17. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
[TBL] [Abstract][Full Text] [Related]
18. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance.
Patel MP; Hu L; Brown CA; Sun Z; Adamski CJ; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
J Biol Chem; 2018 Nov; 293(46):17971-17984. PubMed ID: 30275013
[TBL] [Abstract][Full Text] [Related]
20. Antagonism between substitutions in β-lactamase explains a path not taken in the evolution of bacterial drug resistance.
Brown CA; Hu L; Sun Z; Patel MP; Singh S; Porter JR; Sankaran B; Prasad BVV; Bowman GR; Palzkill T
J Biol Chem; 2020 May; 295(21):7376-7390. PubMed ID: 32299911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
